| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
168 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
854 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
266 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
743 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
866 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6369082 |
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
Apr. 9, 2002 |
| 6369084 |
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
Apr. 9, 2002 |
| 6369048 |
Methods and compositions for inactivating viruses |
Apr. 9, 2002 |
| 6365583 |
Methods to enhance white blood cell count |
Apr. 2, 2002 |
| 6362174 |
Reduced dipeptide analogues as calcium channel antagonitsts |
Mar. 26, 2002 |
| 6358941 |
Treatment of arthritis disorders, rheumatoid arthritis and manifestations associated with rheumatoid disorders |
Mar. 19, 2002 |
| 6358976 |
Integrin receptor antagonists |
Mar. 19, 2002 |
| 6358980 |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors |
Mar. 19, 2002 |
| 6355629 |
Prodrugs with enhanced penetration into cells |
Mar. 12, 2002 |
| 6355651 |
Certain pyrrolopyridine derivatives; novel CRF1 specific ligands |
Mar. 12, 2002 |
| 6352695 |
Methods and compositions for the selective modification of nucleic acids |
Mar. 5, 2002 |
| 6352977 |
Substituted .beta.-alanines |
Mar. 5, 2002 |
| 6352981 |
Substituted AZA- and diazacycloheptane and -cyclooctane |
Mar. 5, 2002 |
| 6352994 |
Substituted 1H-pyridinyl-2-ones as GABAA alpha 2/3 ligands |
Mar. 5, 2002 |
| 6353001 |
2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides |
Mar. 5, 2002 |
| 6348476 |
Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases |
Feb. 19, 2002 |
| 6346524 |
Cancer treatment with temozolomide |
Feb. 12, 2002 |
| 6346283 |
Use of valeriana for the treatment of restless leg syndrome and related disorders |
Feb. 12, 2002 |
| 6344485 |
Method for treating glaucoma |
Feb. 5, 2002 |
| 6342492 |
Anti-viral triaza compounds and compositions |
Jan. 29, 2002 |
| 6340679 |
Guanidine derivatives as inhibitors of cell adhesion |
Jan. 22, 2002 |
| 6337345 |
Insecticidal or miticidal combinations containing chlorfenapyr |
Jan. 8, 2002 |
| 6333305 |
Antibiotic TKR2999, process for the preparation thereof and microbe |
Dec. 25, 2001 |
| 6331531 |
Method for controlling harmful organisms in crops of useful plants |
Dec. 18, 2001 |
| 6331564 |
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
Dec. 18, 2001 |
| 6329338 |
Derivatives of cyclodepsipeptide PF1022 substance |
Dec. 11, 2001 |
| 6329359 |
Substituted benzyl oximino compounds |
Dec. 11, 2001 |
| 6323194 |
Muscarinic agonists and antagonists |
Nov. 27, 2001 |
| 6316413 |
Peptide agonists of bradykinin B2 receptor |
Nov. 13, 2001 |
| 6316433 |
Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
Nov. 13, 2001 |
| 6316434 |
Assay for emetic activity |
Nov. 13, 2001 |
| 6316440 |
Reduced dipeptide analogues as calcium channel antagonists |
Nov. 13, 2001 |
| 6313097 |
Antagonists of calcitonin gene-related peptide |
Nov. 6, 2001 |
| 6313109 |
Prenyl transferase inhibitors |
Nov. 6, 2001 |
| 6310073 |
Methods and compositions to treat glycosaminoglycan-associated molecular interactions |
Oct. 30, 2001 |
| 6306847 |
Condensed purine derivatives |
Oct. 23, 2001 |
| 6306912 |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
Oct. 23, 2001 |
| 6303661 |
Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals |
Oct. 16, 2001 |
| 6297230 |
Cyanoaziridines for treating cancer |
Oct. 2, 2001 |
| 6297246 |
Serotonin 5-HT3, receptor partial activator |
Oct. 2, 2001 |
| 6294525 |
Reverse-turn mimetics and methods relating thereto |
Sep. 25, 2001 |
| 6294542 |
Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
Sep. 25, 2001 |
| 6291446 |
Therapeutic treatment for cytomegalovirus infection |
Sep. 18, 2001 |
| 6291447 |
Granulatimide compounds and uses thereof |
Sep. 18, 2001 |
| 6288053 |
Use of protein kinase C inhibitors to enhance the clinical efficacy of radiation therapy |
Sep. 11, 2001 |
| 6284751 |
Therapeutic treatment for VEGF related diseases |
Sep. 4, 2001 |
| 6284770 |
Medicaments for the treatment of non-constipated female irritable bowel syndrome |
Sep. 4, 2001 |
| 6284797 |
Topical treatment of pain and to promote healing |
Sep. 4, 2001 |
| 6281206 |
Amidino protease inhibitors |
Aug. 28, 2001 |
| 6277839 |
Biphenylene lactams as prostaglandin receptor ligands |
Aug. 21, 2001 |
|
|
|
